Approvisionnement et évaluation de la qualité des eaux souterraines de Selembao et Kimbanseke
Revue congolaise des sciences humaines et sociales · 2021
DOI: 10.59189/crsh102240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revue congolaise des sciences humaines et sociales, 2021. Verfasst von Florent Mukeba und 4 weiteren Autor:innen.
Abstract (Originalsprache)
In many suburban municipalities in Sub-Saharan African countries, the water used in households comes mainly from groundwater, including wells and streams. These springs are vulnerable due to the prevailing poor hygiene and sanitation conditions, leading to the persistence and recurrence of waterborne diseases. In this research, a study on the use of water resources and an epidemiological survey on waterborne diseases were carried out among users of water points and medical institutions in the suburban communes of Selembao and Kimbanseke in the city of Kinshasa, in the DRC. The results of the survey indicate that the users of the selected water points run the risk of catching waterborne diseases, due to a lack of appropriate hygienic habits and due to high microbiological pollution. Hence the need to raise awareness among those concerned.
Zitieren
APA
Mukeba, F., Kapembo, M., Mpiana, P., Mulaji, C., & Poté, J. (2021). Approvisionnement et évaluation de la qualité des eaux souterraines de Selembao et Kimbanseke. Revue congolaise des sciences humaines et sociales. https://doi.org/10.59189/crsh102240
Vancouver
Mukeba F, Kapembo M, Mpiana P, Mulaji C, Poté J. Approvisionnement et évaluation de la qualité des eaux souterraines de Selembao et Kimbanseke. Revue congolaise des sciences humaines et sociales. 2021. doi:10.59189/crsh102240
BibTeX
@article{Mukeba2021,
author = {Mukeba, Florent and Kapembo, Michel and Mpiana, Pius and Mulaji, Crispin and Poté, John},
title = {Approvisionnement et évaluation de la qualité des eaux souterraines de Selembao et Kimbanseke},
journal = {Revue congolaise des sciences humaines et sociales},
year = {2021},
doi = {10.59189/crsh102240}
}
EUVIMED